Cardiac followed by autologous stem cell transplantation for systemic AL amyloidosis.

被引：0

作者：

Gillmore, JD ^{[1
]}

Wechalekar, AD ^{[1
]}

Goodmarn, HJB ^{[1
]}

Lachmann, HJ ^{[1
]}

Offer, M ^{[1
]}

Joshi, J ^{[1
]}

Hawkins, RN ^{[1
]}

机构：

[1] Royal Free & UCL Med Sch, Natl Amyloidsis Ctr, London, England

来源：

BLOOD | 2005年 / 106卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1158

引用

页码：338A / 338A

页数：1

共 50 条

[11] Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation [J].

Jolanta B. Perz ;

Arnt V. Kristen ;

Amin Rahemtulla ;

Jayan Parameshwar ;

Falk-Udo Sack ;

Jane F. Apperley ;

Hartmut Goldschmidt ;

Hugo A. Katus ;

Thomas J. Dengler .

Clinical Research in Cardiology, 2006, 95 :671-674

[12] Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis [J].

Carretero, Marcelina ;

Villanueva, Eugenia ;

Brulc, Erika B. ;

Faelo, Franco M. ;

Aguirre, Maria A. ;

Perez-de-Arenaza, Diego ;

Belziti, Cesar A. ;

Arbelbide, Jorge A. ;

Nucifora, Elsa M. ;

Posadas-Martinez, Maria L. .

ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2023, 93 (04) :435-441

[13] High-dose melphalan followed by autologous stem cell transplantation in patients with primary systemic (AL) amyloidosis [J].

Knop, S ;

Lengerke, C ;

Hebart, H ;

Kanz, L ;

Einsele, H .

BONE MARROW TRANSPLANTATION, 2004, 33 :S165-S165

[14] The role of renal transplantation in systemic AL amyloidosis. [J].

Wechalekar, AD ;

Lachmann, HJ ;

Gillmore, JD ;

Goodman, HJB ;

Offer, M ;

Hawkins, PN .

BLOOD, 2005, 106 (11) :976A-977A

[15] Autologous stem cell transplantation in primary systemic amyloidosis.: Results in 34 patients from a single centre [J].

Blade, J. ;

Rovira, M. ;

Esteve, J. ;

Cibeira, M. T. ;

Rosinol, L. ;

Fernandez-Aviles, F. ;

Salamero, O. ;

Martinez, C. ;

Marin, P. ;

Montserrat, E. ;

Carreras, E. .

BONE MARROW TRANSPLANTATION, 2008, 41 :S64-S64

[16] Autologous stem cell transplantation for primary systemic amyloidosis [J].

Comenzo, RL ;

Gertz, MA .

BLOOD, 2002, 99 (12) :4276-4282

[17] Renal outcome in dose-intensive melphalan therapy and autologous stem cell transplantation for AL amyloidosis. [J].

Meier, P ;

Bakr, M ;

Frossard, V ;

Rosselet, A ;

Kovacsovics, T ;

Burnier, M .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 :669A-669A

[18] AUTOLOGOUS STEM-CELL TRANSPLANTATION IN AMYLOIDOSIS AL [J].

MAJOLINO, I ;

MARCENO, R ;

PECORARO, G ;

SCIME, R ;

VASTA, S ;

LIBERTI, G ;

RIZZO, A ;

INDOVINA, A ;

CARONIA, F .

BONE MARROW TRANSPLANTATION, 1993, 11 (01) :85-85

[19] Long term renal outcome of peripheral blood stem cell transplantation on primary systemic (AL) amyloidosis. [J].

Villicana, R ;

Leung, N ;

Gertz, MA .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 :459A-460A

[20] Baseline serum albumin and proteinuria predict renal response after autologous stem cell transplantation in AL amyloidosis. [J].

Leung, N ;

Dispenzieri, A ;

Lacy, MQ ;

Litzow, MR ;

Kumar, SK ;

Hayman, SR ;

Gertz, MA .

BLOOD, 2005, 106 (11) :340A-341A

← 1 2 3 4 5 →